US FDA exempts over 100 devices from 510(k) requirements
This article was originally published in Clinica
Executive Summary
The US FDA has exempted over 100 Class I and II medical devices from pre-market notification, or 510(k), requirements as it believes these products are sufficiently well understood and do not present risks that require pre-market notification review to assure their safety and effectiveness.